Alzheimer’s Researchers Probe New Treatment Paths
Share this @internewscast.com



The commercial failure of Biogen Inc.’s drug Aduhelm is putting new focus on the state of research into the causes of Alzheimer’s disease.

More than six million people in the U.S. are living with the progressive type of dementia, according to the Alzheimer’s Association, an advocacy group.

Share this @internewscast.com
You May Also Like

Get Microsoft Office and 12 Excel Courses for Less Than $80

Disclosure: Our goal is to feature products and services that we think…

Bitcoin’s short-term price prospects slightly improved, but most traders are far from optimistic

A mild sense of hope emerged among Bitcoin (BTC) investors after the…

Philippine Fintech Startup Raises $5.1 Million In Funding Led By Openspace Ventures

Lista cofounders Aaron Villegas and Khriz Lim. Courtesy of Lista Philippine fintech…

Eminem and Snoop Dogg turn into BAYC chars in new music video

Only a year and a half ago, there appeared to be bad…

3M Faces Potentially Billions in Liabilities Over $7.63 Earplugs

A tiny business for 3M foam earplugs for the U.S. military—threatens to…

De-Centralized Autonomous Organization (DAO) For Cryptocurrency Alleged To Be A General Partnership In Sarcuni

Cryptocurrency may be a new thing, but it has to fit into…

New Covid Vaccines Targeting Variants Are Weighed for Fall Booster Campaign

Advisers to U.S. health regulators are set to meet Tuesday to consider…

Small-time investors achieve the 1 BTC dream as Bitcoin holds $20k range

Ever since early Bitcoin (BTC) investors woke up millionaires as the ecosystem…